Ono Pharmaceutical Co., Ltd.
4528.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.06T
Close$
Share Statistics
| Market cap | $1.06 Trillion |
|---|---|
| Enterprise Value | $959.82 Billion |
| Dividend Yield | $80.00 (3.54%) |
| Earnings per Share | $148.49 |
| Beta | 0.14 |
| Outstanding Shares | 469,905,000 |
Return
| Return on Equity | 8.89% |
|---|---|
| Return on Assets | 7.11% |
| Return on Invested Capital | 11.89% |
Valuation & Multiples
| P/E Ratio | 13.92 |
|---|---|
| PEG | 39.03 |
| Price to Sales | 2.1 |
| Price to Book Ratio | 1.23 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | 8.55 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$33.74
Average shareholder expectationRevenue Estimate
$110.57 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$42.01
Average shareholder expectationRevenue Estimate
$114.43 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Ono Pharmaceutical Co., Ltd.
4,206 employees
CEO: Gyo Sagara Ono Pharmaceutical Co., Ltd., along with its affiliated companies, is engaged in the global development, manufacturing, procurement, and sale of a diverse range of pharmaceutical products and diagnostic tools. Its diverse oncology portfo...